Coherus Oncology Inc.

NASDAQ: CHRS
Share price (8/12/25): $0.92
Market cap (8/12/25): $106 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Issuer tender offer – amended

Issuer tender offer

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

O'Donnell-Tormey Jill

Newcomer Lee Nisley

Ryan Michael Lee

Karachun Rita A

News Filter

Reports Second Quarter 2025 Financial Results and Provides Business Update

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Shareholder Vote Results

Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics

BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Proxy related to merger

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission